Maravai LifeSciences Statistics
NASDAQ: MRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.21-0.22 (-2.96%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 7.26 +0.69%
Maravai LifeSciences by the numbers
Maravai LifeSciences has a market capitalization of $2.67 billion based on 148.99M shares outstanding. With trailing EPS of $-0.53, Maravai LifeSciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.9% above its 50-day average and 46.7% above its 200-day average.
Average daily trading volume is 3.33M shares, or about $24.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MRVI valuation vs. peer median
| Metric | MRVI | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.67B | $2.54B | +5% |
| Avg. volume | 3.33M | 1.03M | +223% |
Peer median across 8 companies: PGEN, MBX, ZLAB, LQDA, NAMS, SUPN, HCM, ELVN.
Valuation
- Market cap
- $2.67B
- Price / sales (latest FY)
- 14.38
- EPS (TTM)
- $-0.53
- Shares outstanding
- 148.99M
Price and trading
- Previous close
- 7.43
- Open
- 7.31
- Day range
- 7.01 – 7.37
- 52-week range
- 2.55 – 9.42
- 52-week change
- +116.52%
- Beta
- —
- Volume
- 3.59M
- Average volume
- 3.33M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 2.67B
- Forward Pe
- -73.39
- Eps
- -0.53
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.42
- Week52 Low
- 2.55
- Avg Volume
- 3.33M
- Shares Outstanding
- 148.99M
- Ma50
- 7.14
- Ma200
- 4.91
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -23.46%
- Pct From52w Low
- 183.30%